HEK-293 Cytotoxicity Assays

AS Abigail V. Sharrock
SM Sarah P. McManaway
MR Michelle H. Rich
JM Jeff S. Mumm
IH Ian F. Hermans
MT Moana Tercel
FP Frederik B. Pruijn
DA David F. Ackerley
ask Ask a question
Favorite

HEK-293 cell lines were seeded in 100 µL aliquots into 6.25 mm diameter culture wells at a density of 180,000 cells mL−1. Cells were seeded in RPMI medium supplemented with 1× glutaMAX, 10% fetal calf serum and 1% penicillin/streptomycin. Cells were left to adhere in a humified incubator at 37°C, 5% CO2 for approximately 16 h before being challenged with 100 µL of RPMI medium supplemented with 1× glutaMAX ± 2× the final metronidazole concentration. Cells were incubated at 37°C, 5% CO2 for 48 h. Following challenge, 10 µL of CellTiter 96 Aqueous One Solution Cell Proliferation Assay reagent (Promega) was added to each well (and also to a medium-only containing well to allow for baseline medium absorbance subtraction) and cells were incubated for 1 h further at 37°C, 5% CO2. Absorbance of wells was measured at 490 nm, and the absorbance value of the media-only control well was subtracted from all other measurements. The baseline-subtracted absorbance of challenged wells was compared to that of an unchallenged control well to determine percentage cell viability for each metronidazole concentration. IC50 values (the concentration of compound at which viability was reduced by 50% relative to the unchallenged control) were calculated using a dose-response inhibition four-parameter variable slope equation in GraphPad Prism 7.0 (GraphPad Software Inc). Calculated IC50 values are the averages of at least three biological replicates.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A